Barberio, Joseph; Becraft, Jacob; Ben Chaouch, Zied; … - National Bureau of Economic Research - 2022
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical … performance is the price per dose, while the increased probability of success due to mRNA technology, adjusting the size of the … portfolio, and the possibility of conducting human challenge trials do not significantly improve financial performance. These …